B-POCKET TRANSPLANT FROM HLA-A2 INTO B27 CHANGES REQUIREMENT FOR P-2 ANCHOR RESIDUE IN PEPTIDE PRESENTATION

B-POCKET TRANSPLANT FROM HLA-A2 INTO B27 CHANGES REQUIREMENT FOR P-2 ANCHOR RESIDUE IN PEPTIDE PRESENTATION

Bibliográfalaš dieđut
Váldodahkkit:	Colbert, R, Rowlandjones, S, Mcmichael, A, Frelinger, J
Materiálatiipa:	Journal article
Almmustuhtton:	1993

Geahča maid

Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
Dahkki: Colbert, R, et al.
Almmustuhtton: (1993)

Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
Dahkki: Colbert, R, et al.
Almmustuhtton: (1993)

DIFFERENCES IN PEPTIDE PRESENTATION BETWEEN B27 SUBTYPES - THE IMPORTANCE OF THE P1 SIDE-CHAIN IN MAINTAINING HIGH-AFFINITY PEPTIDE BINDING TO B-ASTERISK-2703
Dahkki: Colbert, R, et al.
Almmustuhtton: (1994)

Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.
Dahkki: Huet, S, et al.
Almmustuhtton: (1990)

Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703.
Dahkki: Colbert, R, et al.
Almmustuhtton: (1994)

Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides.
Dahkki: Griffin, T, et al.
Almmustuhtton: (1997)

An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide.
Dahkki: Dong, T, et al.
Almmustuhtton: (1996)

Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.
Dahkki: Matsui, M, et al.
Almmustuhtton: (1994)

Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27.
Dahkki: Bowness, P, et al.
Almmustuhtton: (1994)

The solvent-inaccessible Cys67 residue of HLA-B27 contributes to T cell recognition of HLA-B27/peptide complexes.
Dahkki: Appel, H, et al.
Almmustuhtton: (2004)

IDENTIFICATION OF T-CELL RECEPTOR RECOGNITION RESIDUES FOR AN INFLUENZA-VIRUS NONAMER PEPTIDE EPITOPE PRESENTED BY HLA B27
Dahkki: Bowness, P, et al.
Almmustuhtton: (1995)

Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
Dahkki: Kollnberger, S, et al.
Almmustuhtton: (2007)

Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies.
Dahkki: Mear, J, et al.
Almmustuhtton: (1999)

HLA class I typing by PCR: HLA-B27 and an African B27 subtype.
Dahkki: Hill, A, et al.
Almmustuhtton: (1991)

The role of HLA-B27 in spondyloarthritis.
Dahkki: Allen, R, et al.
Almmustuhtton: (1999)

HLA-B27-RESTRICTED PEPTIDE PRESENTATION TO CYTOTOXIC T-CELLS IN REACTIVE ARTHRITIS
Dahkki: Bowness, P, et al.
Almmustuhtton: (1995)

Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
Dahkki: McHugh, K, et al.
Almmustuhtton: (2014)

ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients.
Dahkki: Robinson, P, et al.
Almmustuhtton: (2015)

HLA-B27
Dahkki: Bowness, P
Almmustuhtton: (2015)

HOMOCYSTEINE AND HLA B27-ASSOCIATED ARTHROPATHIES
Dahkki: Gao, X, et al.
Almmustuhtton: (1995)

HLA-B27 transgenic rodents express cell surface HLA-B27 heavy chain homodimers and multimers.
Dahkki: Bowness, P, et al.
Almmustuhtton: (2003)

Functional characterisation of HLA-B27 in autoimmunity
Dahkki: Kollnberger, S, et al.
Almmustuhtton: (2001)

Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases.
Dahkki: Kuon, W, et al.
Almmustuhtton: (2001)

Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides
Dahkki: Yang, X, et al.
Almmustuhtton: (2022)

Residue Cys-67 of HLA-B27 contributes to antigen presentation and T cell recognition of HLA-B27 restricted T cell epitopes.
Dahkki: Appel, H, et al.
Almmustuhtton: (2004)

IMMUNOGENIC HIV VARIANT PEPTIDES THAT BIND TO HLA-B8 BUT FAIL TO STIMULATE CYTOTOXIC T-LYMPHOCYTE RESPONSES
Dahkki: Mcadam, S, et al.
Almmustuhtton: (1995)

HLA-B27: natural function and pathogenic role in spondyloarthritis.
Dahkki: McMichael, A, et al.
Almmustuhtton: (2002)

A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.
Dahkki: Moots, R, et al.
Almmustuhtton: (1991)

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
Dahkki: Evans, D, et al.
Almmustuhtton: (2011)

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
Dahkki: Evans, D, et al.
Almmustuhtton: (2011)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
Dahkki: Wong-Baeza, I, et al.
Almmustuhtton: (2011)

Identification and characterisation of cell surface HLA-B27 homodimers
Dahkki: Bird, L, et al.
Almmustuhtton: (2002)

Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding
Dahkki: Walters, L, et al.
Almmustuhtton: (2018)

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.
Dahkki: Braud, V, et al.
Almmustuhtton: (1997)

Importance of a conserved TCR J alpha-encoded tyrosine for T cell recognition of an HLA B27/peptide complex.
Dahkki: Bowness, P, et al.
Almmustuhtton: (1998)

Genotyping HLA-B27 in spondyloarthropathies.
Dahkki: Brown, M, et al.
Almmustuhtton: (1998)

HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
Dahkki: Kollnberger, S, et al.
Almmustuhtton: (2004)

Genetic modulation of antigen presentation by HLA-B27 molecules.
Dahkki: Pazmany, L, et al.
Almmustuhtton: (1992)

Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition.
Dahkki: Tussey, L, et al.
Almmustuhtton: (1994)

Evidence of widespread binding of HLA class I molecules to peptides.
Dahkki: Frelinger, J, et al.
Almmustuhtton: (1990)